Results 171 to 180 of about 1,044,683 (223)

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip. [PDF]

Front Bioeng Biotechnol
Xie Z, Ye J, Gao X, Chen H, Chen M, Lian J, Ma J, Wang H.   +7 more
europepmc   +1 more source

Sintilimab Combined with Nanoparticle Albumin-Bound Paclitaxel-Based Chemotherapy in Severe Locally Advanced or Metastatic Squamous NSCLC Showed Good Efficacy and Safety: A Pilot Retrospective Analysis. [PDF]

Int J Nanomedicine
Zhong Y, Mao Y, Fu X, Huang H.
europepmc   +1 more source

The Efficacy and Safety of Albumin-Bound Paclitaxel Combined With Anlotinib and PD-1/L1 Inhibitors For Treating Patients With Extensive-Stage Small Cell Lung Cancer and Brain Metastasis: A Retrospective Cohort Study. [PDF]

Cancer Med
Li X, Wu, Peng Y, Tang J, Wu Y.
europepmc   +1 more source

Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy. [PDF]

Acta Pharm Sin B
Zhou Z, Luo W, Zheng C, Wang H, Hu R, Deng H, Shen J.   +6 more
europepmc   +1 more source

Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives. [PDF]

Front Pharmacol
Tian Z, Feng Y, Yang Y, Liu X, Qu G, Yang Y, Wang X, Wang J, Zhang P, Yao W.   +9 more
europepmc   +1 more source

Efficacy and safety of nanoparticle albumin-bound paclitaxel plus carboplatin as neoadjuvant chemotherapy for stages III-IV, unresectable ovarian cancer: a single-arm, open-label, phase Ib/II study. [PDF]

BMC Med
Yin L, Jiang W, Liu S, Fu Y, Zhou L, Pei X, Ye S, Shen W, Yang H, Shan B.   +9 more
europepmc   +1 more source

A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer. [PDF]

Sci Rep
Li N, Wu H, Xu X, Wei Q, Ding Y, Liu S, Wu J, Zheng Y, Xu N, Gao Y, Jiang H.   +10 more
europepmc   +1 more source

The efficacy and safety of trastuzumab and albumin-bound paclitaxel with or without pyrotinib as neoadjuvant therapy for HER2-positive breast cancer: a prospective observational cohort study. [PDF]

Gland Surg
Wang Y, Xu Y, Liu X, Li C, Wang J, Zhang X, Shao B, Zhang J.   +7 more
europepmc   +1 more source

The Efficiency and Safety of Triple-Drug Combination of Albumin-Bound Paclitaxel, Anlotinib and PD-1/L1 Inhibitors in the 2^nd or Above Line of Advanced NSCLC: A Retrospective Cohort Study. [PDF]

Cancer Manag Res
Li X, Wu, Tang J, Wu Y.
europepmc   +1 more source